3-cyclobutyl-1-[[4-[3-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]phenyl]methyl]-4-hydroxyimidazol-2-one
C25H29N3O4S — CID 91498119
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-cyclobutyl-1-[[4-[3-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]phenyl]methyl]-4-hydroxyimidazol-2-one
3-cyclobutyl-1-[[4-[3-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]phenyl]methyl]-4-hydroxyimidazol-2-one (PubChem CID 91498119) has the molecular formula C25H29N3O4S and a molecular weight of 467.59 g/mol. Its IUPAC name is 3-cyclobutyl-1-[[4-[3-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]phenyl]methyl]-4-hydroxyimidazol-2-one.
Molecular Properties
| Compound Name | 3-cyclobutyl-1-[[4-[3-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]phenyl]methyl]-4-hydroxyimidazol-2-one |
|---|---|
| PubChem CID | 91498119 |
| Molecular Formula | C25H29N3O4S |
| Molecular Weight | 467.59 g/mol |
| Exact Mass | 467.19 |
| IUPAC Name | 3-cyclobutyl-1-[[4-[3-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]phenyl]methyl]-4-hydroxyimidazol-2-one |
| SMILES | O=c1n(Cc2ccc(-c3cccc(CN4CCS(=O)(=O)CC4)c3)cc2)cc(O)n1C1CCC1 |
| InChI | InChI=1S/C25H29N3O4S/c29-24-18-27(25(30)28(24)23-5-2-6-23)17-19-7-9-21(10-8-19)22-4-1-3-20(15-22)16-26-11-13-33(31,32)14-12-26/h1,3-4,7-10,15,18,23,29H,2,5-6,11-14,16-17H2 |
| InChIKey | RVHDWMUNIRMUSL-UHFFFAOYSA-N |
| XLogP | 3.03 |
| TPSA | 84.54 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 467.59 |
| LogP ≤ 5 | 3.03 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91498119 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.